サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1555687

バイオロジック安全性試験市場：製品タイプ別、試験方法別、試験タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Biologics Safety Testing Market, By Product Type, By Test Method, By Test Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 345 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
バイオロジック安全性試験市場：製品タイプ別、試験方法別、試験タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年08月23日
発行: AnalystView Market Insights
ページ情報: 英文 345 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

バイオロジック安全性試験の市場規模は2023年に38億7,643万米ドルとなり、2024年から2032年にかけてCAGR 11.2％で拡大

バイオロジック安全性試験市場-市場力学

疾患治療におけるバイオロジックの採用拡大が包括的な安全性試験ソリューションの需要を促進

疾患治療におけるバイオロジックの採用拡大が、包括的な安全性試験ソリューションの必要性を大きく後押ししています。バイオロジックががん、自己免疫疾患、希少疾患などの治療法に革命を起こし続ける中、その安全性と有効性を確保することが最重要課題となっています。例えば、FDAは生物学的製剤の承認の急増を報告しており、生物学的製剤は現在、新薬承認全体の30％近くを占めています。世界保健機関（WHO）などの組織は、汚染を防ぎ患者の安全を確保するために、厳格な安全性試験プロトコルの重要性を強調しています。市場に参入するバイオシミラーの増加も、これらの製品が参照バイオロジックと同じ厳しい基準を満たさなければならないことから、強固な安全性試験の必要性を強調しています。

バイオロジックの安全性試験市場-主な洞察

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約11.2%のCAGRで毎年成長すると推定されます。

製品タイプ別では、キットと試薬が2023年に最大の市場シェアを示すと予測されています。

検査法のセグメンテーションに基づくと、2023年には迅速検査が主要タイプでした。

検査タイプ別では、2023年にはエンドトキシン検査が主要タイプに

地域別では、北米が2023年に収益でリードしました。

バイオロジック安全性試験市場-セグメンテーション分析：

バイオロジック安全性試験の世界市場は、製品タイプ、試験方法、試験タイプ、エンドユーザー、地域に基づいてセグメント化されます。

市場は製品タイプに基づいて4つのカテゴリーに分けられる：機器、キット＆試薬、サービス、ソフトウェアです。キット＆試薬は、検査プロセスにおいて不可欠な役割を果たすため、優先順位が最も高く、次いで重要な機能を持つ機器となります。次に優先順位が低いのはソフトウェアで、データ管理をサポートします。

市場は検査方法によって3つのカテゴリーに分けられる：伝統的検査法、迅速検査法、体外検査法です。迅速検査は、迅速に結果を出す効率の良さが優先され、精密で管理された環境を提供する体外検査がそれに続く。伝統的検査は優先順位が最も低く、多くの場合、時間がかかり、先進的でないです。

バイオロジック安全性試験市場-地理的洞察

北米は、大手バイオ医薬品企業の存在、先進ヘルスケアインフラ、FDAのような機関によって確立された厳格な規制枠組みに支えられて、市場を独占しています。欧州は、ドイツ、英国、フランスといった国々が、強固な製薬部門と欧州医薬品庁（EMA）の定める厳格な安全基準の遵守によってリードしています。アジア太平洋地域では、特に中国、日本、インドなどの国々で、バイオ医薬品研究への投資の増加、医療支出の増加、バイオシミラーの台頭が追い風となり、市場が急速に拡大しています。日本のPMDAや中国のNMPAなど、この地域の規制状況の進展も市場成長に寄与しています。一方、ラテンアメリカと中東・アフリカは、他の地域に比べてペースは遅いもの、ヘルスケアインフラの改善とバイオロジック安全性試験の認知度向上に牽引され、緩やかな市場開拓が見られます。

バイオロジック安全性試験市場-競合情勢：

Thermo Fisher Scientific社、Merck KGaA社、Charles River Laboratories社などの主要企業が、無菌試験、エンドトキシン試験、マイコプラズマ検出を含む包括的な安全性試験サービスと製品を提供し、市場を独占しています。これらの業界大手は、試験能力を強化し、ポートフォリオを拡大するため、継続的に研究開発に投資しています。さらに、ザルトリウスAGやロンザ・グループのような企業は、市場での地位を強化し、新たな技術にアクセスするために、中小企業の買収やパートナーシップの形成に注力しています。競合情勢は、特にアジア太平洋地域における新規企業の参入によっても特徴づけられます。アジア太平洋地域では、現地企業がコスト面の優位性と成長するバイオ医薬品市場を活用しています。規制要件が強化され、バイオロジックの需要が増加するにつれて、競争はさらに激化し、安全性試験法の進歩が促進され、各社は品質と革新性による差別化を迫られると予想されます。

目次

第1章 バイオロジック安全性試験市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バイオロジック安全性試験の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 バイオロジック安全性試験産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 バイオロジック安全性試験市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 バイオロジック安全性試験市場情勢

  • バイオロジック安全性試験市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 バイオロジック安全性試験市場- 製品タイプ別

  • 概要
    • セグメントシェア分析
    • 機器
    • キットと試薬
    • サービス
    • ソフトウェア

第8章 バイオロジック安全性試験市場- 試験方法別

  • 概要
    • セグメントシェア分析
    • 伝統的なテスト
    • 迅速検査
    • 体外試験

第9章 バイオロジック安全性試験市場- 試験タイプ別

  • 概要
    • セグメントシェア分析
    • 無菌試験
    • エンドトキシン検査
    • マイコプラズマ検査
    • バイオバーデン試験
    • 残留宿主汚染物質の検出

第10章 バイオロジック安全性試験市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 製薬・バイオテクノロジー企業
    • 受託研究機関（CRO）
    • 学術研究機関
    • 規制機関

第11章 バイオロジック安全性試験市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- バイオロジック安全性試験業界

  • 競合ダッシュボード
  • 企業プロファイル
    • BioOutsource Ltd.（Sartorius）
    • Cambrex Corporation
    • Charles River Biopharmaceutical Services
    • Charles River Laboratories International, Inc.
    • Cytovance Biologics Inc.
    • Eurofins Lancaster Laboratories
    • Eurofins Scientific SE
    • InvivoGen
    • Lonza Group Ltd.
    • Merck KGaA
    • Pace Analytical Services, LLC
    • Sartorius AG
    • SGS SA
    • Thermo Fisher Scientific Inc.
    • Toxikon Corporation
    • WuXi AppTec
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV3718

REPORT HIGHLIGHT

Biologics Safety Testing Market size was valued at USD 3,876.43 Million in 2023, expanding at a CAGR of 11.2% from 2024 to 2032.

The Biologics Safety Testing Market, essential for ensuring the safety and efficacy of biologic products, encompasses various assays and protocols to detect contaminants and ensure compliance with regulatory standards. The increasing adoption of biologics in disease treatment, advancements in cell culture technology, and stringent regulatory frameworks are contributing to the expansion of this market. However, the high costs associated with safety testing procedures and the complexity of biological products pose significant challenges. Despite these challenges, the market presents opportunities in the form of technological advancements in testing methods and the rising demand for biosimilars. Notably, the biologics sector accounts for over 40% of the pharmaceutical pipeline, highlighting the growing need for comprehensive safety testing solutions.

Biologics Safety Testing Market- Market Dynamics

Growing Adoption of Biologics in Disease Treatment Fuels Demand for Comprehensive Safety Testing Solutions

The rising adoption of biologics in disease treatment is significantly driving the need for comprehensive safety testing solutions. As biologics continue to revolutionize therapies for conditions like cancer, autoimmune disorders, and rare diseases, ensuring their safety and efficacy has become paramount. For instance, the FDA has reported a surge in biologic drug approvals, with biologics now representing nearly 30% of all new drug approvals. Organizations like the World Health Organization (WHO) have emphasized the importance of rigorous safety testing protocols to prevent contamination and ensure patient safety. The increasing number of biosimilars entering the market also underscores the need for robust safety testing, as these products must meet the same stringent standards as their reference biologics.

Biologics Safety Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2024-2032)

Based on product type segmentation, Kits & Reagents was predicted to show maximum market share in the year 2023

Based on Test Method segmentation, Rapid Tests were the leading type in 2023

Based on Test Type segmentation, Endotoxin Testing was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Biologics Safety Testing Market- Segmentation Analysis:

The Global Biologics Safety Testing Market is segmented based on Product Type, Test Method, Test Type, End-User, and Region.

The market is divided into four categories based on product type: Instruments, Kits & Reagents, Services, and Software. Kits & Reagents hold the highest priority due to their essential role in testing processes, followed by Instruments for their critical function. Services come next, offering specialized expertise, while Software holds the lowest priority, supporting data management.

The market is divided into three categories based on Test Methods: Traditional Tests, Rapid Tests, and In Vitro Tests. Rapid Tests are prioritized for their efficiency in delivering quick results, followed by In Vitro Tests, which offer precise and controlled environments. Traditional Tests hold the lowest priority, often being time-consuming and less advanced.

Biologics Safety Testing Market- Geographical Insights

North America dominates the market, supported by the presence of major biopharmaceutical companies, advanced healthcare infrastructure, and stringent regulatory frameworks established by agencies like the FDA. Europe follows closely, with countries like Germany, the UK, and France leading due to their robust pharmaceutical sectors and adherence to strict safety standards set by the European Medicines Agency (EMA). In Asia-Pacific, the market is rapidly expanding, fueled by increasing investments in biopharmaceutical research, growing healthcare expenditure, and the rise of biosimilars, particularly in countries like China, Japan, and India. The region's evolving regulatory landscape, such as Japan's PMDA and China's NMPA, is also contributing to market growth. Meanwhile, Latin America and the Middle East & Africa are witnessing gradual market development, driven by improving healthcare infrastructure and rising awareness of biologics safety testing, albeit at a slower pace compared to other regions.

Biologics Safety Testing Market- Competitive Landscape:

Leading companies like Thermo Fisher Scientific, Merck KGaA, and Charles River Laboratories dominate the market, offering a comprehensive range of safety testing services and products, including sterility testing, endotoxin testing, and mycoplasma detection. These industry giants continually invest in R&D to enhance their testing capabilities and expand their portfolios. Additionally, companies like Sartorius AG and Lonza Group are focusing on acquiring smaller firms and forming partnerships to strengthen their market position and access emerging technologies. The competitive landscape is also marked by the entry of new players, particularly in the Asia-Pacific region, where local companies are leveraging cost advantages and growing biopharmaceutical markets. As regulatory requirements tighten and the demand for biologics increases, the competition is expected to further intensify, driving advancements in safety testing methods and pushing companies to differentiate themselves through quality and innovation.

Recent Developments:

In December 2022, WuXi Biologics launched a new biosafety testing center in Shanghai, enhancing its capabilities in the biopharmaceutical sector. This facility aims to support the development of safer and more effective therapies for global health challenges.

In July 2024, SGS North America expanded its biologics testing capabilities at Lincolnshire Center of Excellence, enhancing instrumentation and expertise. This facility supports biopharmaceutical companies in drug development, ensuring compliance with regulatory guidelines and accelerating market entry for biologics products.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGICS SAFETY TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BioOutsource Ltd. (Sartorius)
  • Cambrex Corporation
  • Charles River Biopharmaceutical Services
  • Charles River Laboratories International, Inc.
  • Cytovance Biologics Inc.
  • Eurofins Lancaster Laboratories
  • Eurofins Scientific SE
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Pace Analytical Services, LLC
  • Sartorius AG
  • SGS S.A.
  • Thermo Fisher Scientific Inc.
  • Toxikon Corporation
  • WuXi AppTec
  • Others

GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Kits & Reagents
  • Services
  • Software

GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY TEST METHOD- MARKET ANALYSIS, 2019 - 2032

  • Traditional Tests
  • Rapid Tests
  • In Vitro Tests

GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Sterility Testing
  • Endotoxin Testing
  • Mycoplasma Testing
  • Bioburden Testing
  • Residual Host Contaminant Detection

GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Regulatory Bodies

GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biologics Safety Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biologics Safety Testing Market Snippet by Product Type
    • 2.1.2. Biologics Safety Testing Market Snippet by Test Method
    • 2.1.3. Biologics Safety Testing Market Snippet by Test Type
    • 2.1.4. Biologics Safety Testing Market Snippet by End-User
    • 2.1.5. Biologics Safety Testing Market Snippet by Country
    • 2.1.6. Biologics Safety Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Biologics Safety Testing Key Market Trends

  • 3.1. Biologics Safety Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biologics Safety Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biologics Safety Testing Market Opportunities
  • 3.4. Biologics Safety Testing Market Future Trends

4. Biologics Safety Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biologics Safety Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biologics Safety Testing Market Landscape

  • 6.1. Biologics Safety Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biologics Safety Testing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Instruments
    • 7.1.3. Kits & Reagents
    • 7.1.4. Services
    • 7.1.5. Software

8. Biologics Safety Testing Market - By Test Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Test Method, 2023 & 2032 (%)
    • 8.1.2. Traditional Tests
    • 8.1.3. Rapid Tests
    • 8.1.4. In Vitro Tests

9. Biologics Safety Testing Market - By Test Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 9.1.2. Sterility Testing
    • 9.1.3. Endotoxin Testing
    • 9.1.4. Mycoplasma Testing
    • 9.1.5. Bioburden Testing
    • 9.1.6. Residual Host Contaminant Detection

10. Biologics Safety Testing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical & Biotechnology Companies
    • 10.1.3. Contract Research Organizations (CROs)
    • 10.1.4. Academic & Research Institutes
    • 10.1.5. Regulatory Bodies

11. Biologics Safety Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Biologics Safety Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Biologics Safety Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Biologics Safety Testing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Biologics Safety Testing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Biologics Safety Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Test Method, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Biologics Safety Testing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. BioOutsource Ltd. (Sartorius)
    • 12.2.2. Cambrex Corporation
    • 12.2.3. Charles River Biopharmaceutical Services
    • 12.2.4. Charles River Laboratories International, Inc.
    • 12.2.5. Cytovance Biologics Inc.
    • 12.2.6. Eurofins Lancaster Laboratories
    • 12.2.7. Eurofins Scientific SE
    • 12.2.8. InvivoGen
    • 12.2.9. Lonza Group Ltd.
    • 12.2.10. Merck KGaA
    • 12.2.11. Pace Analytical Services, LLC
    • 12.2.12. Sartorius AG
    • 12.2.13. SGS S.A.
    • 12.2.14. Thermo Fisher Scientific Inc.
    • 12.2.15. Toxikon Corporation
    • 12.2.16. WuXi AppTec
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us